About Event

Running digitally for 2020, Gene Therapy for Neurological Disorders Europe will unite industry leaders to help them overcome their translational challenges and successfully bring their CNS gene therapy candidate into the clinic.

5 Unmissable Highlights


Walk through the development of a gene therapy administrated with intraparenchymal delivery with uniQure

Navigate clinical endpoints for rare disease clinical
trials with AveXis

Discover engineering strategies for cell-specific targeting in the brain with Voyager

Explore appropriate promoter choices for CNS indications as suggested by AskBio

Tackle regulatory challenges for neurological
gene therapy development with advice from the EMA

Download the full event guide for more information.